Objective To investigate the effect of conversion from cyelosporine A ( CsA ) to tacrolimus ( Tac) on chronic allograft nephropathy ( CAN) . Methods 153 CAN patients undergoing kidney transplantation received CsA,myco...Objective To investigate the effect of conversion from cyelosporine A ( CsA ) to tacrolimus ( Tac) on chronic allograft nephropathy ( CAN) . Methods 153 CAN patients undergoing kidney transplantation received CsA,mycophenolate mofetil ( MMF) and展开更多
Key points： PRATO-ACS randomized NSTE-ACS patients to rosuvastatin or control prior to PCI Statin resulted in significant decrease in nephropathy, better short-term outcomes Data needed to elucidate class effects of ...Key points： PRATO-ACS randomized NSTE-ACS patients to rosuvastatin or control prior to PCI Statin resulted in significant decrease in nephropathy, better short-term outcomes Data needed to elucidate class effects of statins, causality展开更多
文摘Objective To investigate the effect of conversion from cyelosporine A ( CsA ) to tacrolimus ( Tac) on chronic allograft nephropathy ( CAN) . Methods 153 CAN patients undergoing kidney transplantation received CsA,mycophenolate mofetil ( MMF) and
文摘Key points： PRATO-ACS randomized NSTE-ACS patients to rosuvastatin or control prior to PCI Statin resulted in significant decrease in nephropathy, better short-term outcomes Data needed to elucidate class effects of statins, causality
